VeriMomVeriMom

dibromopropamidine diisethionate é seguro durante a gravidez?

No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.

Ingredientes
dibromopropamidine diisethionate
SEM RISCOS CONHECIDOS
93
/100
0

Related ingredients

Frequently asked questions

dibromopropamidine diisethionate é seguro durante a gravidez?
No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.
dibromopropamidine diisethionate é seguro durante a amamentação?
No evidence of reproductive or developmental hazard or mechanism specific to this compound was found. Because topical/ophthalmic use leads to low but measurable systemic exposure, a low exposure score is assigned for lactation; no data on milk transfer were located. Sources: PubChem entry, product/labeling references indicating topical ophthalmic use; no PubMed studies on lactation or milk transfer were found.
dibromopropamidine diisethionate é seguro para a pele do bebê?
No infant-specific reproductive or mechanistic evidence was found. The ingredient is used in topical/ophthalmic products (including products for children in some markets), and immature infant skin has higher per‑kg exposure; therefore exposure is scored one category higher than adult topical use. No data were found showing increased hazard or specific infant toxicity. Sources: product/medicinal listings showing pediatric topical/ophthalmic use and pharmacopoeial references; absence of reproductive/toxicity studies in PubMed.
Como o VeriMom pontua dibromopropamidine diisethionate?
O VeriMom pontua dibromopropamidine diisethionate em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
Quais são as alternativas seguras a dibromopropamidine diisethionate na gravidez?
Veja nossa lista curada de alternativas seguras a dibromopropamidine diisethionate com base em função semelhante e classificação sem riscos conhecidos.

Verifique qualquer rótulo em 2 segundos

Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.

Aviso Médico

Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.

Tenha a experiência completa no app VeriMom